000177445 001__ 177445
000177445 005__ 20240229133740.0
000177445 037__ $$aDKFZ-2021-02537
000177445 1001_ $$0P:(DE-He78)036b60c419272e509b5b5db5246c13bc$$aGenard, Geraldine$$b0$$udkfz
000177445 1112_ $$aThe 5th Edition of the International Conference on Immunotherapy Radiotherapy Combinations$$cParis$$d2021-09-14 - 2021-09-17$$wFrance
000177445 245__ $$aCarbon-ion therapy for immune activation in solid cancer: focus on small extracellular vesicles
000177445 260__ $$c2021
000177445 3367_ $$033$$2EndNote$$aConference Paper
000177445 3367_ $$2DataCite$$aOther
000177445 3367_ $$2BibTeX$$aINPROCEEDINGS
000177445 3367_ $$2DRIVER$$aconferenceObject
000177445 3367_ $$2ORCID$$aLECTURE_SPEECH
000177445 3367_ $$0PUB:(DE-HGF)6$$2PUB:(DE-HGF)$$aConference Presentation$$bconf$$mconf$$s1637151828_27175$$xInvited
000177445 520__ $$aSince the immune system is recognized as a determinant factor for tumor growth, most of new anticancer therapeutic strategies have been orientated to target immune cells. Interestingly, radiotherapy (RT) has in some instances the potential to act as an adjuvant for the tumor immune system. Some technical advances in radiotherapy has revolutionized the clinical care of patients, such as the use of charged particles. Charged particles allow a better sparing of healthy tissues and has a higher relative biological effectiveness than conventional RT (X-rays and γ-rays). In this context, recent works reported a broader activation of the immune system in patients and tumor mouse models with charged particle therapy, and more specifically with carbon ion therapy, as compared to X-rays. However, to date, no study has deciphered the immune cellular and molecular changes mediated by charged particle therapy in the tumor microenvironment. For conventional RT (X-rays), it is known that the immune response can be mediated by a crosstalk between cancer cells and immune cells, involving small extracellular vesicles (sEVs), also named exosomes, which have the potential to travel through the body to reach different targeted cells. In this project, we decipher key biological questions: How does carbon ion therapy influence the immune response in cancer and how does this therapy affect sEV cargos in order to better understand the immune response triggered by carbon ions and possibly to associate radiotherapy to new immune-targeted drugs. Finally, diagnostic and prognostic factors are also planned to be evaluated on patients, treated at the Heidelberg Ion Therapy (HIT) center (Carbon ions) or Heidelberg hospital (X-rays).
000177445 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000177445 7001_ $$0P:(DE-He78)d06e5bb2d0828caa2be79a51825e84e1$$aPagliari, Francesca$$b1$$udkfz
000177445 7001_ $$0P:(DE-He78)102624aca75cfe987c05343d5fdcf2fe$$aSeco, Joao$$b2$$eCorresponding author$$udkfz
000177445 909CO $$ooai:inrepo02.dkfz.de:177445$$pVDB
000177445 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)036b60c419272e509b5b5db5246c13bc$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000177445 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d06e5bb2d0828caa2be79a51825e84e1$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000177445 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)102624aca75cfe987c05343d5fdcf2fe$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000177445 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000177445 9141_ $$y2021
000177445 9201_ $$0I:(DE-He78)E041-20160331$$kE041$$lE041 Medizinische Physik in der Radioonkologie$$x0
000177445 980__ $$aconf
000177445 980__ $$aVDB
000177445 980__ $$aI:(DE-He78)E041-20160331
000177445 980__ $$aUNRESTRICTED